939,305 results on '"Virology"'
Search Results
2. A Laboratory Manual for Introductory Virology Based Upon Developmental Studies with Bacterial and Animal Viruses. Final Technical Report.
- Author
-
Wong, Connie
- Abstract
This manual provides numerous experiments for college-level microbiology students illustrating the basic principles in phage, tissue culture, and animal virology. (CS)
- Published
- 1974
3. Interferon as a General Antiviral Agent
- Author
-
Baron, Samuel
- Abstract
Reviews the role of interferon, (a nonspecific antiviral protein developed by mammals, birds, a reptile and fish after infection), in recovery from virus infection. (AL)
- Published
- 1972
4. Integrative Virology for Senior Medical Students.
- Author
-
Koment, Roger W.
- Abstract
The article describes a senior elective in virology developed at the University of South Dakota School of Medicine. Students work independently through a series of course units, selecting 12 study topics from a catalog of 35 topics in medical virology and discussing their reading daily with the professor. (DB)
- Published
- 1991
5. Results of the Sukuma Ndoda (“Stand up, Man”) HIV Self-Screening and Assisted Linkage to Care Project in Johannesburg: A Quasi-Experimental Pre–Post Evaluation
- Author
-
Lippman, Sheri A, Grignon, Jessica S, Ditshwane, Boitumelo, West, Rebecca L, Gilmore, Hailey J, Mazibuko, Sipho, Mongwe, Livhuwani G, Neilands, Torsten B, Gutin, Sarah A, O’Connor, Cara, Santana, Maideline A, and Majam, Mohammed
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,Clinical Sciences ,HIV/AIDS ,Behavioral and Social Science ,Women's Health ,Clinical Research ,Infectious Diseases ,Clinical Trials and Supportive Activities ,Prevention ,Sexually Transmitted Infections ,Health Services ,Infection ,Good Health and Well Being ,Humans ,Male ,HIV Infections ,South Africa ,Adult ,Middle Aged ,Mass Screening ,Young Adult ,Self-Testing ,HIV Testing ,Community Health Workers ,Adolescent ,HIV self-screening ,HIV self-testing ,linkage to care ,men ,Public Health and Health Services ,Virology ,Clinical sciences ,Epidemiology ,Public health - Abstract
BackgroundHIV testing rates among South African men lag behind rates for women and national targets. Community-based HIV self-screening (HIVSS) distribution and follow-up by community health workers (CHWs) is a scalable option to increase testing coverage, diagnosis, and treatment initiation. We provided HIVSS and assisted linkage to care to men not recently tested (within the past 12 months) residing in high-HIV-burden areas of Johannesburg.MethodsCHWs distributed HIVSS in 6 clinic catchment areas. Follow-up to encourage confirmatory testing and antiretroviral therapy initiation was conducted through personal support (PS) or an automated short message service (SMS) follow-up and linkage system in 3 clinic areas each. Using a quasi-experimental pre-post design, we compared differences in the proportion of men testing in the clinic catchment areas during the HIVSS campaign (June-August 2019) to the 3 months prior (March-May 2019) and compared treatment initiations by assisted linkage strategy.ResultsAmong 4793 participants accepting HIVSS, 62% had never tested. Among 3993 participants with follow-up data, 90.6% reported using their HIVSS kit. Testing coverage among men increased by 156%, from under 4% when only clinic-based HIV testing services were available to 9.5% when HIVSS and HIV testing services were available (z = -11.6; P < 0.01). Reported test use was higher for men followed through PS (99% vs. 68% in SMS); however, significantly more men reported reactive self-test results in the SMS group compared with PS (6.4% vs. 2.0%), resulting in more antiretroviral therapy initiations in the SMS group compared with PS (23 vs. 9; P < 0.01).ConclusionsCHW HIVSS distribution significantly increases testing among men. While PS enabled personalized follow-up, reporting differences indicate SMS is more acceptable and better aligned with expectations of privacy associated with HIVSS.
- Published
- 2024
6. The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidence.
- Author
-
Alwine, James, Goodrum, Felicia, Banfield, Bruce, Bloom, David, Britt, William J, Broadbent, Andrew J, Campos, Samuel K, Casadevall, Arturo, Chan, Gary C, Cliffe, Anna R, Dermody, Terence, Duprex, Paul, Enquist, Lynn W, Frueh, Klaus, Geballe, Adam P, Gaglia, Marta, Goldstein, Stephen, Greninger, Alexander L, Gronvall, Gigi Kwick, Jung, Jae U, Kamil, Jeremy P, Lakdawala, Seema, Liu, Shan-Lu, Luftig, Micah, Moore, John P, Moscona, Anne, Neuman, Benjamin W, Nikolich, Janko Ž, O'Connor, Christine, Pekosz, Andrew, Permar, Sallie, Pfeiffer, Julie, Purdy, John, Rasmussen, Angela, Semler, Bert, Smith, Gregory A, Stein, David A, Van Doorslaer, Koenraad, Weller, Sandra K, Whelan, Sean PJ, and Yurochko, Andrew
- Subjects
Agricultural ,Veterinary and Food Sciences ,Biological Sciences ,Biomedical and Clinical Sciences ,Emerging Infectious Diseases ,Coronaviruses ,Infectious Diseases ,Life on Land ,COVID-19 ,SARS-CoV-2 ,anti-science ,lab leak ,origin ,pandemic ,science advocacy ,science policy ,spillover ,zoonosis ,Agricultural and Veterinary Sciences ,Medical and Health Sciences ,Virology ,Agricultural ,veterinary and food sciences ,Biological sciences ,Biomedical and clinical sciences - Abstract
Science is humanity's best insurance against threats from nature, but it is a fragile enterprise that must be nourished and protected. The preponderance of scientific evidence indicates a natural origin for SARS-CoV-2. Yet, the theory that SARS-CoV-2 was engineered in and escaped from a lab dominates media attention, even in the absence of strong evidence. We discuss how the resulting anti-science movement puts the research community, scientific research, and pandemic preparedness at risk.
- Published
- 2024
7. Interferon-signaling pathways are upregulated in people with HIV with abnormal pulmonary diffusing capacity (DLCO)
- Author
-
Zhang, Michelle, Dai, Guorui, Smith, Dana L, Zacco, Emanuela, Shimoda, Michiko, Kumar, Nitasha, Girling, Valerie, Gardner, Kendall, Hunt, Peter W, Huang, Laurence, and Lin, Jue
- Subjects
Biomedical and Clinical Sciences ,Immunology ,Genetics ,Lung ,Sexually Transmitted Infections ,HIV/AIDS ,Infectious Diseases ,2.1 Biological and endogenous factors ,Good Health and Well Being ,Humans ,HIV Infections ,Cross-Sectional Studies ,Signal Transduction ,Male ,Pulmonary Diffusing Capacity ,Female ,Interferons ,Middle Aged ,Adult ,Pilot Projects ,Up-Regulation ,Gene Expression Profiling ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Virology ,Biomedical and clinical sciences ,Health sciences - Abstract
ObjectivePeople with HIV (PWH) are at greater risk of developing lung diseases even when they are antiretroviral therapy (ART)-adherent and virally suppressed. The most common pulmonary function abnormality in PWH is that of impaired diffusing capacity of the lungs for carbon monoxide (DL CO ), which is an independent risk factor for increased mortality in PWH. Earlier work has identified several plasma biomarkers of inflammation and immune activation to be associated with decreased DL CO . However, the underpinning molecular mechanisms of HIV-associated impaired DL CO are largely unknown.DesignCross-sectional pilot study with PWH with normal DL CO (values greater than or equal to the lower limit of normal, DL CO ≥ LLN, N = 9) or abnormal DL CO (DL CO
- Published
- 2024
8. Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small molecules
- Author
-
Kadiyala, Gayatri Nikhila, Telwatte, Sushama, Wedrychowski, Adam, Janssens, Julie, Kim, Sun Jin, Kim, Peggy, Deeks, Steven, Wong, Joseph K, and Yukl, Steven A
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Immunology ,HIV/AIDS ,Infectious Diseases ,Sexually Transmitted Infections ,Genetics ,5.1 Pharmaceuticals ,6.1 Pharmaceuticals ,Infection ,Humans ,Indoles ,HIV Infections ,Pyrroles ,Leukocytes ,Mononuclear ,Proviruses ,apoptosis ,Bcl-2 ,DNA ,HIV ,IAP ,interferon ,mTOR ,PD-1 ,proteasome ,RIG-I ,TLR7 ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Virology ,Biomedical and clinical sciences ,Health sciences - Abstract
ObjectivesSome drugs that augment cell-intrinsic defenses or modulate cell death/survival pathways have been reported to selectively kill cells infected with HIV or Simian Immunodeficiency Virus (SIV), but comparative studies are lacking. We hypothesized that these drugs may differ in their ability to kill cells infected with intact and defective proviruses.DesignTo investigate this hypothesis, drugs were tested ex vivo on peripheral blood mononuclear cells (PBMC) from nine antiretroviral therapy (ART)-suppressed individuals.MethodsWe tested drugs currently in clinical use or human trials, including auranofin (p53 modulator), interferon alpha2A, interferon gamma, acitretin (RIG-I inducer), GS-9620/vesatolimod (TLR7 agonist), nivolumab (PD-1 blocker), obatoclax (Bcl-2 inhibitor), birinapant [inhibitor of apoptosis proteins (IAP) inhibitor], bortezomib (proteasome inhibitor), and INK128/sapanisertib [mammalian target of rapamycin mTOR] [c]1/2 inhibitor). After 6 days of treatment, we measured cell counts/viabilities and quantified levels of total, intact, and defective HIV DNA by droplet digital PCR (Intact Proviral DNA Assay).ResultsObatoclax reduced intact HIV DNA [median = 27-30% of dimethyl sulfoxide control (DMSO)] but not defective or total HIV DNA. Other drugs showed no statistically significant effects.ConclusionObatoclax and other Bcl-2 inhibitors deserve further study in combination therapies aimed at reducing the intact HIV reservoir in order to achieve a functional cure and/or reduce HIV-associated immune activation.
- Published
- 2024
9. Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery
- Author
-
Shivakoti, Rupak, Giganti, Mark J, Lederman, Michael M, Ketchum, Rachel, Brummel, Sean, Moisi, Daniela, Dadabhai, Sufia, Moodley, Dhayendre, Violari, Avy, Chinula, Lameck, Owor, Maxensia, Gupta, Amita, Currier, Judith S, Taha, Taha E, Fowler, Mary Glenn, and team, for the PROMISE study
- Subjects
Reproductive Medicine ,Biomedical and Clinical Sciences ,Perinatal Period - Conditions Originating in Perinatal Period ,Preterm ,Low Birth Weight and Health of the Newborn ,HIV/AIDS ,Infectious Diseases ,Pediatric ,Women's Health ,Clinical Trials and Supportive Activities ,Clinical Research ,Sexually Transmitted Infections ,Pregnancy ,Evaluation of treatments and therapeutic interventions ,6.1 Pharmaceuticals ,Infection ,Reproductive health and childbirth ,Good Health and Well Being ,Humans ,Female ,HIV Infections ,Premature Birth ,Adult ,Inflammation ,Case-Control Studies ,Pregnancy Complications ,Infectious ,Anti-HIV Agents ,Biomarkers ,Zidovudine ,Tenofovir ,Antiretroviral Therapy ,Highly Active ,Lopinavir ,Young Adult ,PROMISE study team ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Virology ,Biomedical and clinical sciences ,Health sciences - Abstract
ObjectiveHIV treatment regimen during pregnancy was associated with preterm delivery (PTD) in the PROMISE 1077 BF trial. Systemic inflammation among pregnant women with HIV could help explain differences in PTD by treatment regimen. We assessed associations between inflammation, treatment regimen, and PTD.Design/methodsA nested 1 : 1 case-control study ( N = 362) was conducted within a multicountry randomized trial comparing three HIV regimens in pregnant women: zidovudine alone, or combination antiretroviral therapy (ART) with lopinavir/ritonavir and either zidovudine or tenofovir. Cases were women with PTD (
- Published
- 2024
10. The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies
- Author
-
Ayoub, Samantha M, Holloway, Breanna M, Miranda, Alannah H, Roberts, Benjamin Z, Young, Jared W, Minassian, Arpi, and Ellis, Ronald J
- Subjects
Pharmacology and Pharmaceutical Sciences ,Biomedical and Clinical Sciences ,Prevention ,Infectious Diseases ,Substance Misuse ,Sexually Transmitted Infections ,Cannabinoid Research ,Drug Abuse (NIDA only) ,Behavioral and Social Science ,Clinical Trials and Supportive Activities ,HIV/AIDS ,Neurosciences ,Clinical Research ,Mental health ,Humans ,HIV Infections ,Cognition ,Cannabis ,Cannabinoids ,Animals ,Cognitive Dysfunction ,Marijuana Use ,NeuroHIV ,HIV-associated neurocognitive disorders ,Immunology ,Medical Microbiology ,Virology ,Clinical sciences - Abstract
Purpose of reviewCannabis may have beneficial anti-inflammatory effects in people with HIV (PWH); however, given this population's high burden of persisting neurocognitive impairment (NCI), clinicians are concerned they may be particularly vulnerable to the deleterious effects of cannabis on cognition. Here, we present a systematic scoping review of clinical and preclinical studies evaluating the effects of cannabinoid exposure on cognition in HIV.Recent findingsResults revealed little evidence to support a harmful impact of cannabis use on cognition in HIV, with few eligible preclinical data existing. Furthermore, the beneficial/harmful effects of cannabis use observed on cognition were function-dependent and confounded by several factors (e.g., age, frequency of use). Results are discussed alongside potential mechanisms of cannabis effects on cognition in HIV (e.g., anti-inflammatory), and considerations are outlined for screening PWH that may benefit from cannabis interventions. We further highlight the value of accelerating research discoveries in this area by utilizing translatable cross-species tasks to facilitate comparisons across human and animal work.
- Published
- 2024
11. Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection.
- Author
-
Zheng, Weihao, Chang, I-Chang, Limberis, Jason, Budzik, Jonathan M, Zha, Beth Shoshana, Howard, Zachary, Chen, Lucas, and Ernst, Joel D
- Subjects
Biochemistry and Cell Biology ,Biomedical and Clinical Sciences ,Biological Sciences ,Rare Diseases ,Infectious Diseases ,Lung ,Tuberculosis ,Aetiology ,2.1 Biological and endogenous factors ,Infection ,Good Health and Well Being ,Monocytes ,Lysosomes ,Macrophages ,Alveolar ,Animals ,Mice ,Inbred C57BL ,Humans ,Mice ,Mycobacterium tuberculosis ,Tuberculosis ,Pulmonary ,Chronic Disease ,Basic Helix-Loop-Helix Leucine Zipper Transcription Factors ,Microbiology ,Immunology ,Medical Microbiology ,Virology ,Medical microbiology - Abstract
Mycobacterium tuberculosis (Mtb) infects lung myeloid cells, but the specific Mtb-permissive cells and host mechanisms supporting Mtb persistence during chronic infection are incompletely characterized. We report that after the development of T cell responses, CD11clo monocyte-derived cells harbor more live Mtb than alveolar macrophages (AM), neutrophils, and CD11chi monocyte-derived cells. Transcriptomic and functional studies revealed that the lysosome pathway is underexpressed in this highly permissive subset, characterized by less lysosome content, acidification, and proteolytic activity than AM, along with less nuclear TFEB, a regulator of lysosome biogenesis. Mtb infection does not drive lysosome deficiency in CD11clo monocyte-derived cells but promotes recruitment of monocytes that develop into permissive lung cells, mediated by the Mtb ESX-1 secretion system. The c-Abl tyrosine kinase inhibitor nilotinib activates TFEB and enhances lysosome functions of macrophages in vitro and in vivo, improving control of Mtb infection. Our results suggest that Mtb exploits lysosome-poor lung cells for persistence and targeting lysosome biogenesis is a potential host-directed therapy for tuberculosis.
- Published
- 2024
12. Assessing transmission attribution risk from simulated sequencing data in HIV molecular epidemiology
- Author
-
Nascimento, Fabrícia F, Mehta, Sanjay R, Little, Susan J, and Volz, Erik M
- Subjects
Health Sciences ,HIV/AIDS ,Behavioral and Social Science ,Genetics ,Biotechnology ,Generic health relevance ,Infection ,Male ,Humans ,Molecular Epidemiology ,HIV Infections ,Homosexuality ,Male ,Sexual and Gender Minorities ,Probability ,Phylogeny ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Virology ,Biomedical and clinical sciences ,Health sciences - Abstract
BackgroundHIV molecular epidemiology (ME) is the analysis of sequence data together with individual-level clinical, demographic, and behavioral data to understand HIV epidemiology. The use of ME has raised concerns regarding identification of the putative source in direct transmission events. This could result in harm ranging from stigma to criminal prosecution in some jurisdictions. Here we assessed the risks of ME using simulated HIV genetic sequencing data.MethodsWe simulated social networks of men-who-have-sex-with-men, calibrating the simulations to data from San Diego. We used these networks to simulate consensus and next-generation sequence (NGS) data to evaluate the risks of identifying direct transmissions using different HIV sequence lengths, and population sampling depths. To identify the source of transmissions, we calculated infector probability and used phyloscanner software for the analysis of consensus and NGS data, respectively.ResultsConsensus sequence analyses showed that the risk of correctly inferring the source (direct transmission) within identified transmission pairs was very small and independent of sampling depth. Alternatively, NGS analyses showed that identification of the source of a transmission was very accurate, but only for 6.5% of inferred pairs. False positive transmissions were also observed, where one or more unobserved intermediaries were present when compared to the true network.ConclusionSource attribution using consensus sequences rarely infers direct transmission pairs with high confidence but is still useful for population studies. In contrast, source attribution using NGS data was much more accurate in identifying direct transmission pairs, but for only a small percentage of transmission pairs analyzed.
- Published
- 2024
13. Feasibility of Implementing a Low-Barrier Long-Acting Injectable Antiretroviral Program for HIV Treatment and Prevention for People Experiencing Homelessness
- Author
-
Mehtani, Nicky J, Strough, Alix, Strieff, Sarah, Zevin, Barry, Eveland, Joanna, Riley, Elise D, and Gandhi, Monica
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,Mental Health ,HIV/AIDS ,Clinical Research ,Homelessness ,Infectious Diseases ,Prevention ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Infection ,Good Health and Well Being ,Humans ,Adult ,HIV Infections ,Anti-HIV Agents ,Feasibility Studies ,Viremia ,Anti-Retroviral Agents ,Ill-Housed Persons ,Pre-Exposure Prophylaxis ,Clinical Sciences ,Public Health and Health Services ,Virology ,Clinical sciences ,Epidemiology ,Public health - Abstract
BackgroundLong-acting (LA) antiretrovirals may provide meaningful benefit to people who use drugs and people experiencing homelessness (PEH) who face disproportionate structural and psychosocial barriers in adhering to daily oral HIV antiretroviral therapy or pre-exposure prophylaxis (PrEP), but their use in these populations has not been studied.SettingThe Maria X. Martinez Health Resource Center is a low-barrier (eg, no appointment) community-based clinic serving San Francisco PEH.MethodsA multidisciplinary care model with robust monitoring and outreach support was developed to provide LA antiretroviral therapy (ART) and LA-PrEP to eligible patients experiencing difficulties adhering to oral antiretrovirals. Feasibility was assessed by evaluating the rates of HIV viremia and on-time injections among patients receiving LA antiretrovirals over the first 24 months of program implementation.ResultsBetween November 2021 and November 2023, 33 patients initiated LA-ART or LA-PrEP (median age, 37 years; 27% transgender/nonbinary; 73% non-White; 27% street homeless; 52% sheltered homeless; 30% with opioid use disorder; 82% with methamphetamine use disorder). Among 18 patients with HIV, 14 initiated LA-ART injections with detectable viremia (median CD4 count, 340 cells/mm 3 ; mean log 10 viral load, 3.53; SD, 1.62), 8 had never previously been virally suppressed, and all but 1 achieved or maintained virologic suppression (mean, 9.67 months; SD, 8.30). Among 15 LA-PrEP patients, all remained HIV negative (mean, 4.73 months; SD, 2.89). Of 224 total injections administered, 8% were delayed >7 days.DiscussionThe implementation of LA antiretrovirals is feasible in low-barrier, highly supportive clinical settings serving vulnerable PEH. Expansion of such programs will be critical in ending the HIV epidemic.
- Published
- 2024
14. Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postnatal Care Clinics in Rural Uganda and Kenya
- Author
-
Kabami, Jane, Koss, Catherine A, Sunday, Helen, Biira, Edith, Nyabuti, Marilyn, Balzer, Laura B, Gupta, Shalika, Chamie, Gabriel, Ayieko, James, Kakande, Elijah, Bacon, Melanie C, Havlir, Diane, Kamya, Moses R, Petersen, Maya, and Team, SEARCH Study
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,Clinical Sciences ,Prevention ,HIV/AIDS ,Behavioral and Social Science ,Health Services ,Clinical Research ,Sexually Transmitted Infections ,Pediatric ,Women's Health ,Clinical Trials and Supportive Activities ,Infectious Diseases ,3.1 Primary prevention interventions to modify behaviours or promote wellbeing ,Reproductive health and childbirth ,Good Health and Well Being ,Female ,Humans ,Pregnancy ,HIV Infections ,Kenya ,Postnatal Care ,Postpartum Period ,Pre-Exposure Prophylaxis ,Uganda ,Adolescent ,Young Adult ,HIV ,PrEP ,PEP ,antenatal care ,postnatal care ,person-centered ,SEARCH Study Team ,Public Health and Health Services ,Virology ,Clinical sciences ,Epidemiology ,Public health - Abstract
BackgroundPregnant and postpartum women in Sub-Saharan Africa are at high risk of HIV acquisition. We evaluated a person-centered dynamic choice intervention for HIV prevention (DCP) among women attending antenatal and postnatal care.SettingRural Kenya and Uganda.MethodsWomen (aged 15 years or older) at risk of HIV acquisition seen at antenatal and postnatal care clinics were individually randomized to DCP vs. standard of care (SEARCH; NCT04810650). The DCP intervention included structured client choice of product (daily oral pre-exposure prophylaxis or postexposure prophylaxis), service location (clinic or out of facility), and HIV testing modality (self-test or provider-administered), with option to switch over time and person-centered care (phone access to clinician, structured barrier assessment and counseling, and provider training). The primary outcome was biomedical prevention coverage-proportion of 48-week follow-up with self-reported pre-exposure prophylaxis or postexposure prophylaxis use, compared between arms using targeted maximum likelihood estimation.ResultsBetween April and July 2021, we enrolled 400 women (203 intervention and 197 control); 38% were pregnant, 52% were aged 15-24 years, and 94% reported no pre-exposure prophylaxis or postexposure prophylaxis use for ≥6 months before baseline. Among 384/400 participants (96%) with outcome ascertained, DCP increased biomedical prevention coverage 40% (95% CI: 34% to 47%; P < 0.001); the coverage was 70% in intervention vs. 29% in control. DCP also increased coverage during months at risk of HIV (81% in intervention, 43% in control; 38% absolute increase; 95% CI: 31% to 45%; P < 0.001).ConclusionA person-centered dynamic choice intervention that provided flexibility in product, testing, and service location more than doubled biomedical HIV prevention coverage in a high-risk population already routinely offered access to biomedical prevention options.
- Published
- 2024
15. Bacterial resistance to temperate phage is influenced by the frequency of lysogenic establishment
- Author
-
Baaziz, Hiba, Makhlouf, Rita, McClelland, Michael, and Hsu, Bryan B
- Subjects
Microbiology ,Biological Sciences ,Ecology ,Infectious Diseases ,Antimicrobial Resistance ,Emerging Infectious Diseases ,Infection ,Viral microbiology ,Virology - Abstract
Temperate phages can shape bacterial community dynamics and evolution through lytic and lysogenic life cycles. In response, bacteria that resist phage infection can emerge. This study explores phage-based factors that influence bacterial resistance using a model system of temperate P22 phage and Salmonella both inside and outside the mammalian host. Phages that remained functional despite gene deletions had minimal impact on lysogeny and phage resistance except for deletions in the immI region that substantially reduced lysogeny and increased phage resistance to levels comparable to that observed with an obligately lytic P22. This immI deletion does not make the lysogen less competitive but instead increases the frequency of bacterial lysis. Thus, subtle changes in the balance between lysis and lysogeny during the initial stages of infection can significantly influence the extent of phage resistance in the bacterial population. Our work highlights the complex nature of the phage-bacteria-mammalian host triad.
- Published
- 2024
16. Life course history of physical and sexual abuse is associated with cardiovascular disease risk among women living with and without HIV
- Author
-
Appleton, Allison A, Kuniholm, Mark H, Vásquez, Elizabeth, Cohen, Mardge H, Donohue, Jessica, Floris-Moore, Michelle, Friedman, M Reuel, Hanna, David B, Mimiaga, Matthew J, Moran, Caitlin A, Plankey, Michael W, Teplin, Linda A, Shitole, Sanyog G, Ware, Deanna, Jones, Deborah L, and Wise, Jenni
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,Cardiovascular ,Pediatric ,Infectious Diseases ,Drug Abuse (NIDA only) ,Heart Disease ,Prevention ,Substance Misuse ,Behavioral and Social Science ,HIV/AIDS ,Clinical Research ,2.3 Psychological ,social and economic factors ,Aetiology ,Good Health and Well Being ,Humans ,Female ,Child ,Adult ,HIV Infections ,Cardiovascular Diseases ,Life Change Events ,Sex Offenses ,Sexual Behavior ,Risk Factors ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Virology ,Biomedical and clinical sciences ,Health sciences - Abstract
ObjectiveSexual and physical abuse predict cardiovascular disease (CVD) among women in the general population. Women living with HIV (WLWH) report more abuse and have higher CVD risk compared with other women, yet associations between abuse history and CVD have not been considered among WLWH. This study fills this gap, and describes possible pathways linking abuse to CVD risk among WLWH and women living without HIV (WLWOH).MethodsUsing 25 years of data from the Women's Interagency HIV Study (WIHS; n = 2734; WLWH n = 1963; WLWOH n = 771), we used longitudinal generalized estimating equations (GEE) to test associations between sexual and physical abuse with CVD risk. Framingham (FRS-H) and the American College of Cardiology/American Heart Association-Pooled Cohort Equation (ACC/AHA-PCE) scores were examined. Analyses were stratified by HIV-serostatus.ResultsAmong WLWH, childhood sexual abuse was associated with higher CVD risk ( βFRS-H = 1.25, SE = 1.08, P = 0.005; βACC/AHA-PCE = 1.14, SE = 1.07, P = 0.04) compared with no abuse. Adulthood sexual abuse was associated with higher CVD risk for WLWH ( βFRS-H = 1.39, SE = 1.08, P
- Published
- 2024
17. Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?
- Author
-
Lee, Daniel and Capeau, Jacqueline
- Subjects
Biomedical and Clinical Sciences ,Health Sciences ,Humans ,Glucagon-Like Peptide-1 Receptor Agonists ,HIV Infections ,Glucagon-Like Peptides ,Weight Loss ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Virology ,Biomedical and clinical sciences ,Health sciences - Published
- 2024
18. Targeting ABCG1 and SREBP-2 mediated cholesterol homeostasis ameliorates Zika virus-induced ocular pathology
- Author
-
Singh, Sneha, Wright, Robert E, Giri, Shailendra, Arumugaswami, Vaithilingaraja, and Kumar, Ashok
- Subjects
Biomedical and Clinical Sciences ,Ophthalmology and Optometry ,Neurosciences ,Biodefense ,Digestive Diseases ,Orphan Drug ,Vector-Borne Diseases ,Infectious Diseases ,Emerging Infectious Diseases ,Liver Disease ,Rare Diseases ,Genetics ,Eye Disease and Disorders of Vision ,2.2 Factors relating to the physical environment ,Aetiology ,2.1 Biological and endogenous factors ,Infection ,Good Health and Well Being ,Molecular biology ,Virology - Abstract
Zika virus (ZIKV) infection during pregnancy causes severe neurological and ocular abnormalities in infants, yet no vaccine or antivirals are available. Our transcriptomic analysis of ZIKV-infected retinal pigment epithelial (RPE) cells revealed alterations in the cholesterol pathway. Thus, we investigated the functional roles of ATP binding cassette transporter G1 (ABCG1) and sterol response element binding protein 2 (SREPB-2), two key players in cholesterol metabolism, during ocular ZIKV infection. Our in vitro data showed that increased ABCG1 activity via liver X receptors (LXRs), reduced ZIKV replication, while ABCG1 knockdown increased replication with elevated intracellular cholesterol. Conversely, inhibiting SREBP-2 or its knockdown reduced ZIKV replication by lowering cholesterol levels. In vivo, LXR agonist or SREBP-2 inhibitor treatment mitigated ZIKV-induced chorioretinal lesions in mice, concomitant with decreased expression of inflammatory mediators and increased activation of antiviral response genes. In summary, our study identifies ABCG1's antiviral role and SREBP-2's proviral effects in ocular ZIKV infection, offering cholesterol metabolism as a potential target to develop antiviral therapies.
- Published
- 2024
19. Longitudinal analysis of CSF HIV RNA in untreated people with HIV: Identification of CSF controllers
- Author
-
Trunfio, Mattia, Tang, Bin, Okwuegbuna, Oluwakemi, Iudicello, Jennifer E, Bharti, Ajay, Moore, David J, Gelman, Benjamin B, Morgello, Susan, Patel, Payal B, Rubin, Leah H, Ances, Beau M, Gianella, Sara, Heaton, Robert K, Ellis, Ronald J, and Letendre, Scott L
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Immunology ,HIV/AIDS ,Infectious Diseases ,Clinical Research ,Neurosciences ,2.1 Biological and endogenous factors ,Aetiology ,Infection ,Good Health and Well Being ,Humans ,HIV-1 ,RNA ,Viral ,HIV Infections ,Iron ,Serum Globulins ,Viral Load ,CSF control ,CSF/plasma discordance ,HIV viral load ,antiretroviral naïve ,blood–brain barrier ,central nervous system ,Microbiology ,Virology ,Clinical sciences ,Medical microbiology - Abstract
Interindividual variation of human immunodeficiency virus (HIV) RNA setpoint in cerebrospinal fluid (CSF) and its determinants are poorly understood, but relevant for HIV neuropathology, brain reservoirs, viral escape, and reseeding after antiretroviral interruptions. Longitudinal multicentric study on demographic, clinical, and laboratory correlates of CSF HIV RNA in 2000 follow-up visits from 597 people with HIV (PWH) off antiretroviral therapy (ART) and with plasma HIV RNA > the lower limit of quantification (LLQ). Factors associated with CSF control (CSFC; CSF HIV RNA LLQ) and with CSF/plasma discordance (CSF > plasma HIV RNA > LLQ) were also assessed through mixed-effects models. Posthoc and sensitivity analyses were performed for persistent CSFC and ART-naïve participants, respectively. Over a median follow-up of 2.1 years, CSF HIV RNA was associated with CD4+ and CD8+ T cells, CSF leukocytes, blood-brain barrier (BBB) integrity, biomarkers of iron and lipid metabolism, serum globulins, past exposure to lamivudine, and plasma HIV RNA (model p
- Published
- 2024
20. Effects of a hospital discharge clinic among people with HIV: Lack of early follow‐up is associated with 30‐day hospital readmission and decreased retention in care
- Author
-
Hill, Lucas, Thompson, Courtney, Balcombe, Shannon, Jain, Sonia, He, Feng, Karris‐Young, Maile, Martin, Thomas CS, Karim, Afsana, Bamford, Laura, and Deiss, Robert
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,HIV/AIDS ,Clinical Research ,Good Health and Well Being ,Humans ,Patient Readmission ,Patient Discharge ,Retention in Care ,Follow-Up Studies ,Retrospective Studies ,HIV Infections ,Hospitals ,HIV ,readmissions ,substance use disorder ,transitions of care ,Virology ,Clinical sciences ,Epidemiology - Abstract
BackgroundThe transition between inpatient and outpatient care for hospitalized people with HIV represents an opportunity for linkage and re-engagement in care. We evaluated whether attendance at a post-hospitalization visit ('discharge clinic') within 1-2 weeks of discharge would reduce readmissions and improve retention in care (RIC) among people with HIV in San Diego, California, USA.MethodsThis was a retrospective cohort study of people with HIV hospitalized between June 2020 and November 2021. Our primary outcome was 30-day readmissions among people with HIV who did or did not attend a discharge clinic visit. Secondary outcomes included the effect of discharge clinic attendance on RIC, along with the impact of attendance at any HIV clinic visit within 30 days of discharge on readmissions and RIC.ResultsWe evaluated 114 people with HIV, of whom 77 (67.5%) and 90 (78.9%) attended a discharge clinic visit or any HIV clinic visit within 30 days of discharge, respectively. Active substance use disorder (SUD) was associated with failing to attend a discharge clinic visit (odds ratio 0.31; 95% confidence interval 0.13-0.77). We observed no significant differences in readmissions between people with HIV who did or did not attend a discharge clinic visit; however, the former had significantly higher 6-month RIC (79.2% vs. 35.1%, p
- Published
- 2024
21. Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
- Author
-
Dulin, Harrison, Barre, Ramya, Xu, Duo, Neal, Arrmund, Vizcarra, Edward, Chavez, Jerald, Ulu, Arzu, Yang, Myeon-Sik, Khan, Siddiqur, Wuang, Keidy, Bhakta, Nikhil, Chea, Chanvoraboth, Martinez-Sobrido, Luis, Hai, Rong, and Wilson, Emma
- Subjects
SARS-CoV-2 ,emerging virus ,vaccine ,virology ,Humans ,Animals ,Mice ,SARS-CoV-2 ,Antibody Formation ,Influenza A Virus ,H1N1 Subtype ,COVID-19 ,Antibodies ,Neutralizing ,Spike Glycoprotein ,Coronavirus ,Antibodies ,Viral ,Influenza Vaccines ,Nucleoproteins - Abstract
In pandemic scenarios involving novel human pathogenic viruses, it is highly desirable that vaccines induce strong neutralizing antibodies as quickly as possible. However, current vaccine strategies require multiple immunization doses to produce high titers of neutralizing antibodies and are poorly protective after a single vaccination. We therefore wished to design a vaccine candidate that would induce increased protective immune responses following the first vaccine dose. We hypothesized that antibodies against the receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein could be increased by drawing upon immunity to a previous infection. We generated a fusion protein containing the influenza H1N1 PR8 virus nucleoprotein (NP) and the SARS-CoV-2 spike RBD. Mice with or without preexisting immunity to PR8 were then vaccinated with NP/RBD. We observed significantly increased SARS-CoV-2 neutralizing antibodies in mice with PR8 immunity compared to mice without preexisting PR8 immunity. Vaccination with NP/RBD protected mice from SARS-CoV-2-induced morbidity and mortality after a single dose. Additionally, we compared SARS-CoV-2 virus titers in the lungs and nasal turbinates 4 days post-challenge of mice vaccinated with NP/RBD. SARS-CoV-2 virus was detectable in the lungs and nasal turbinate of mice without preexisting PR8 immunity, while SARS-CoV-2 virus was completely undetectable in mice with preexisting PR8 immunity. We also found that CD4-positive T cells in mice with preexisting immunity to PR8 play an essential role in producing the increased antibody response against RBD. This vaccine strategy potentially can be modified to target other pathogens of concern and offers extra value in future pandemic scenarios.IMPORTANCEIncreased globalization and changes in human interactions with wild animals has increased the likelihood of the emergence of novel viruses with pandemic potential. Vaccines can be effective in preventing severe disease caused by pandemic viruses. However, it takes time to develop protective immunity via prime-boost vaccination. More effective vaccine designs should quickly induce protective immunity. We propose leveraging preexisting immunity to a different pathogen to boost protection against emerging viruses. We targeted SARS-CoV-2 as a representative pandemic virus and generated a fusion protein vaccine that combines the nucleoprotein from influenza A virus and the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Our vaccine design significantly increased the production of RBD-specific antibodies in mice that had previously been exposed to influenza virus, compared to those without previous exposure. This enhanced immunity reduced SARS-CoV-2 replication in mice. Our results offer a vaccine design that could be valuable in a future pandemic setting.
- Published
- 2024
22. Kaposi’s sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation
- Author
-
Nakajima, Ken-ichi, Inagaki, Tomoki, Espera, Jonna Magdallene, and Izumiya, Yoshihiro
- Subjects
Microbiology ,Biochemistry and Cell Biology ,Biological Sciences ,Human Genome ,Emerging Infectious Diseases ,Biotechnology ,HIV/AIDS ,Infectious Diseases ,Genetics ,Prevention ,Infection ,Humans ,Antigens ,Viral ,DNA ,Herpesvirus 8 ,Human ,Indoleacetic Acids ,Nucleotidyltransferases ,Plasmids ,Sarcoma ,Kaposi ,Virus Latency ,Nuclear Proteins ,KSHV ,latency ,episome ,protein knockdown ,Agricultural and Veterinary Sciences ,Medical and Health Sciences ,Virology ,Agricultural ,veterinary and food sciences ,Biological sciences ,Biomedical and clinical sciences - Abstract
Protein knockdown with an inducible degradation system is a powerful tool for studying proteins of interest in living cells. Here, we adopted the auxin-inducible degron (AID) approach to detail Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) function in latency maintenance and inducible viral lytic gene expression. We fused the mini-auxin-inducible degron (mAID) tag at the LANA N-terminus with KSHV bacterial artificial chromosome 16 recombination, and iSLK cells were stably infected with the recombinant KSHV encoding mAID-LANA. Incubation with 5-phenyl-indole-3-acetic acid, a derivative of natural auxin, rapidly degraded LANA within 1.5 h. In contrast to our hypothesis, depletion of LANA alone did not trigger lytic reactivation but rather decreased inducible lytic gene expression when we stimulated reactivation with a combination of ORF50 protein expression and sodium butyrate. Decreased overall lytic gene induction seemed to be associated with a rapid loss of KSHV genomes in the absence of LANA. The rapid loss of viral genomic DNA was blocked by a lysosomal inhibitor, chloroquine. Furthermore, siRNA-mediated knockdown of cellular innate immune proteins, cyclic AMP-GMP synthase (cGAS) and simulator of interferon genes (STING), and other autophagy-related genes rescued the degradation of viral genomic DNA upon LANA depletion. Reduction of the viral genome was not observed in 293FT cells that lack the expression of cGAS. These results suggest that LANA actively prevents viral genomic DNA from sensing by cGAS-STING signaling axis, adding novel insights into the role of LANA in latent genome maintenance.IMPORTANCESensing of pathogens' components is a fundamental cellular immune response. Pathogens have therefore evolved strategies to evade such cellular immune responses. KSHV LANA is a multifunctional protein and plays an essential role in maintaining the latent infection by tethering viral genomic DNA to the host chromosome. We adopted the inducible protein knockdown approach and found that depletion of LANA induced rapid degradation of viral genomic DNA, which is mediated by innate immune DNA sensors and autophagy pathway. These observations suggest that LANA may play a role in hiding KSHV episome from innate immune DNA sensors. Our study thus provides new insights into the role of LANA in latency maintenance.
- Published
- 2024
23. Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters
- Author
-
Izumiya, Yoshihiro, Algalil, Adhraa, Espera, Jonna M, Miura, Hiroki, Izumiya, Chie, Inagaki, Tomoki, and Kumar, Ashish
- Subjects
Biochemistry and Cell Biology ,Biological Sciences ,Emerging Infectious Diseases ,Infectious Diseases ,Lymphoma ,Cancer ,Hematology ,Lymphatic Research ,Rare Diseases ,Genetics ,Biotechnology ,Underpinning research ,1.1 Normal biological development and functioning ,Infection ,Generic health relevance ,Humans ,Herpesvirus 8 ,Human ,Histones ,Nucleosomes ,Immediate-Early Proteins ,Virus Latency ,Antigens ,Viral ,Terminal Repeat Sequences ,Gene Expression Regulation ,Viral ,Sarcoma ,Kaposi ,Kaposi's sarcoma-associated herpesvirus ,transcriptional regulation ,reactivation ,RNA polymerases ,latency ,enhancer ,BRD4 ,CHD4 ,herpesviruses ,Agricultural and Veterinary Sciences ,Medical and Health Sciences ,Virology ,Agricultural ,veterinary and food sciences ,Biological sciences ,Biomedical and clinical sciences - Abstract
The Kaposi's sarcoma-associated herpesvirus (KSHV) genome consists of an approximately 140-kb unique coding region flanked by 30-40 copies of a 0.8-kb terminal repeat (TR) sequence. A gene enhancer recruits transcription-related enzymes by having arrays of transcription factor binding sites. Here, we show that KSHV TR possesses transcription regulatory function with latency-associated nuclear antigen (LANA). Cleavage under targets and release using nuclease demonstrated that TR fragments were occupied by LANA-interacting histone-modifying enzymes in naturally infected cells. The TR was enriched with histone H3K27 acetylation (H3K27Ac) and H3K4 tri-methylation (H3K4me3) modifications and also expressed nascent RNAs. The sites of H3K27Ac and H3K4me3 modifications were also conserved in the KSHV unique region among naturally infected primary effusion lymphoma cells. KSHV origin of lytic replication (Ori-Lyt) showed similar protein and histone modification occupancies with that of TR. In the Ori-Lyt region, the LANA and LANA-interacting proteins colocalized with an H3K27Ac-modified nucleosome along with paused RNA polymerase II. The KSHV transactivator KSHV replication and transcription activator (K-Rta) recruitment sites franked the LANA-bound nucleosome, and reactivation evicted the LANA-bound nucleosome. Including TR fragments in reporter plasmid enhanced inducible viral gene promoter activities independent of the orientations. In the presence of TR in reporter plasmids, K-Rta transactivation was drastically increased, while LANA acquired the promoter repression function. KSHV TR, therefore, functions as an enhancer for KSHV inducible genes. However, in contrast to cellular enhancers bound by multiple transcription factors, perhaps the KSHV enhancer is predominantly regulated by the LANA nuclear body.IMPORTANCEEnhancers are a crucial regulator of differential gene expression programs. Enhancers are the cis-regulatory sequences determining target genes' spatiotemporal and quantitative expression. Here, we show that Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeats fulfill the enhancer definition for KSHV inducible gene promoters. The KSHV enhancer is occupied by latency-associated nuclear antigen (LANA) and its interacting proteins, such as CHD4. Neighboring terminal repeat (TR) fragments to lytic gene promoters drastically enhanced KSHV replication and transcription activator and LANA transcription regulatory functions. This study, thus, proposes a new latency-lytic switch model in which TR accessibility to the KSHV gene promoters regulates viral inducible gene expression.
- Published
- 2024
24. Facility HIV Self-Testing in Outpatient Departments: An Assessment of Characteristics and Concerns of Outpatients Who Opt Out of Testing in Malawi
- Author
-
Shaba, Frackson, Balakasi, Kelvin T, Offorjebe, Ogechukwu A, Nyirenda, Mike, Wong, Vincent J, Gupta, Sundeep K, Hoffman, Risa M, and Dovel, Kathryn
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,Clinical Sciences ,Infectious Diseases ,HIV/AIDS ,Prevention ,Behavioral and Social Science ,Sexually Transmitted Infections ,Clinical Research ,Clinical Trials and Supportive Activities ,Infection ,Adult ,Humans ,Male ,HIV Infections ,HIV ,Outpatients ,Self-Testing ,Malawi ,HIV Testing ,Mass Screening ,sub-Saharan Africa ,HIV self-testing ,barriers to care ,outpatient department ,Public Health and Health Services ,Virology ,Clinical sciences ,Epidemiology ,Public health - Abstract
BackgroundFacility HIV self-testing (HIVST) in outpatient departments can dramatically increase testing among adult outpatients. However, it is still unclear why populations opt out of facility HIVST and reasons for opt outing. Using data from a parent facility HIVST trial, we sought to understand individual characteristics associated with opting out of facility HIVST and reported reasons for not testing.MethodsExit surveys were conducted with outpatients aged ≥15 years at 5 facilities in Central and Southern Malawi randomized to the facility HIVST arm of the parent trial. Outpatients were eligible for our substudy if they were offered HIVST and eligible for HIV testing (ie, never previously tested HIV positive and tested ≥12 months ago or never tested). Summary statistics and multivariate regression models were used.ResultsSeven hundred seventy-one outpatients were included in the substudy. Two hundred sixty-three (34%) opted out of HIVST. Urban residency (adjusted risk ratios [aRR] 3.48; 95% CI: 1.56 to 7.76) and self-reported poor health (aRR 1.86; 95% CI: 1.27 to 2.72) were associated with an increased risk of opting out. Male participants had a 69% higher risk of opting out (aRR 1.69; 95% CI: 1.14 to 2.51), with risk being 38% lower among working male participants. Primary reasons for not testing were feeling unprepared to test (49·4%) and perceived low risk of HIV infection (30·4%)-only 2.6% believed that HIVST instructions were unclear, and 1.7% were concerned about privacy.ConclusionWorking, risky sexual behavior, rural residence, and good self-rated health were positively associated with opting out of HIVST among outpatients. Strategies to address internalized barriers, such as preparedness to test and perceived need to test, should be incorporated into facility HIVST interventions.
- Published
- 2024
25. Leveraging social networks for identification of people with HIV who are virally unsuppressed
- Author
-
Cummins, Breschine, Johnson, Kara, Schneider, John A, Del Vecchio, Natascha, Moshiri, Niema, Wertheim, Joel O, Goyal, Ravi, and Skaathun, Britt
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,HIV/AIDS ,Clinical Research ,Infection ,Male ,Humans ,HIV Infections ,Sexual Partners ,Sexual and Gender Minorities ,Social Networking ,Contact Tracing ,contact tracing ,engagement ,HIV ,people with HIV ,recruitment ,social networks ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Virology ,Biomedical and clinical sciences ,Health sciences - Abstract
ObjectivesThis study investigates primary peer-referral engagement (PRE) strategies to assess which strategy results in engaging higher numbers of people with HIV (PWH) who are virally unsuppressed.DesignWe develop a modeling study that simulates an HIV epidemic (transmission, disease progression, and viral evolution) over 6 years using an agent-based model followed by simulating PRE strategies. We investigate two PRE strategies where referrals are based on social network strategies (SNS) or sexual partner contact tracing (SPCT).MethodsWe parameterize, calibrate, and validate our study using data from Chicago on Black sexual minority men to assess these strategies for a population with high incidence and prevalence of HIV. For each strategy, we calculate the number of PWH recruited who are undiagnosed or out-of-care (OoC) and the number of direct or indirect transmissions.ResultsSNS and SPCT identified 256.5 [95% confidence interval (CI) 234-279] and 15 (95% CI 7-27) PWH, respectively. Of these, SNS identified 159 (95% CI 142-177) PWH OoC and 32 (95% CI 21-43) PWH undiagnosed compared with 9 (95% CI 3-18) and 2 (95% CI 0-5) for SPCT. SNS identified 15.5 (95% CI 6-25) and 7.5 (95% CI 2-11) indirect and direct transmission pairs, whereas SPCT identified 6 (95% CI 0-8) and 5 (95% CI 0-8), respectively.ConclusionWith no testing constraints, SNS is the more effective strategy to identify undiagnosed and OoC PWH. Neither strategy is successful at identifying sufficient indirect or direct transmission pairs to investigate transmission networks.
- Published
- 2024
26. People with HIV at the end-of-life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related research
- Author
-
Ndukwe, Samuel O, Patel, Hursch, Shelton, Brittany, Concha-Garcia, Susanna, Dullano, Cheryl, Solso, Stephanie, Hendrickx, Steven, Riggs, Patricia K, Villa, Thomas J, Kaytes, Andy, Taylor, Jeff, Little, Susan J, Lessard, David, Arora, Anish K, Costiniuk, Cecilia T, Eskaf, Shadi, Smith, Davey M, Gianella, Sara, and Dubé, Karine
- Subjects
Biomedical and Clinical Sciences ,Immunology ,Clinical Research ,Infectious Diseases ,HIV/AIDS ,Clinical Trials and Supportive Activities ,Good Health and Well Being ,Humans ,United States ,HIV Infections ,Surveys and Questionnaires ,Cognition ,Death ,altruism ,end of life ,HIV cure research ,Last Gift ,rapid research autopsy ,socio-behavioral research ,willingness to participate ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Virology ,Biomedical and clinical sciences ,Health sciences - Abstract
IntroductionThe Last Gift study at the University of California San Diego (UCSD), United States enrolls terminally ill people with HIV (PWH) in HIV cure research.MethodsFrom 2017 to 2022, we conducted surveys with Last Gift participants and their next-of-kin/loved ones to evaluate willingness to participate in different types of HIV cure research at the end of life (EOL). We analyzed willingness data descriptively.ResultsWe surveyed 17 Last Gift participants and 17 next-of-kin/loved ones. More than half of Last Gift participants ( n = 10; 58.8%) expressed willingness to participate in studies involving totally new treatments or approaches ('first-in-human' studies), a combination of different approaches, the use of unique antibodies, proteins or molecules, or therapeutic vaccines. Under one-quarter of Last Gift participants ( n = 4; 23.5%) expressed willingness to participate in research involving interventions that may shorten their life expectancy to benefit medical research. Most Last Gift participants and their next-of-kin/loved ones also expressed high acceptance for various types of donations and biopsies at the EOL (e.g. hair donations and skin, lymph node or gut biopsies).DiscussionKnowing whether people would be willing to participate in different types of EOL HIV cure research can help inform the design of future innovative studies. As a research community, we have a duty to design studies with adequate safeguards to preserve the public trust in research and honor PWH's important gift to humanity.
- Published
- 2024
27. Progression of herpesvirus infection remodels mitochondrial organization and metabolism
- Author
-
Leclerc, Simon, Gupta, Alka, Ruokolainen, Visa, Chen, Jian-Hua, Kunnas, Kari, Ekman, Axel A, Niskanen, Henri, Belevich, Ilya, Vihinen, Helena, Turkki, Paula, Perez-Berna, Ana J, Kapishnikov, Sergey, Mäntylä, Elina, Harkiolaki, Maria, Dufour, Eric, Hytönen, Vesa, Pereiro, Eva, McEnroe, Tony, Fahy, Kenneth, Kaikkonen, Minna U, Jokitalo, Eija, Larabell, Carolyn A, Weinhardt, Venera, Mattola, Salla, Aho, Vesa, and Vihinen-Ranta, Maija
- Subjects
Medical Microbiology ,Biochemistry and Cell Biology ,Biomedical and Clinical Sciences ,Biological Sciences ,Infectious Diseases ,Sexually Transmitted Infections ,2.1 Biological and endogenous factors ,2.2 Factors relating to the physical environment ,Aetiology ,Infection ,Mitochondria ,Herpesvirus 1 ,Human ,Humans ,Herpes Simplex ,Animals ,Herpesviridae Infections ,Disease Progression ,Chlorocebus aethiops ,Microbiology ,Immunology ,Virology ,Medical microbiology - Abstract
Viruses target mitochondria to promote their replication, and infection-induced stress during the progression of infection leads to the regulation of antiviral defenses and mitochondrial metabolism which are opposed by counteracting viral factors. The precise structural and functional changes that underlie how mitochondria react to the infection remain largely unclear. Here we show extensive transcriptional remodeling of protein-encoding host genes involved in the respiratory chain, apoptosis, and structural organization of mitochondria as herpes simplex virus type 1 lytic infection proceeds from early to late stages of infection. High-resolution microscopy and interaction analyses unveiled infection-induced emergence of rough, thin, and elongated mitochondria relocalized to the perinuclear area, a significant increase in the number and clustering of endoplasmic reticulum-mitochondria contact sites, and thickening and shortening of mitochondrial cristae. Finally, metabolic analyses demonstrated that reactivation of ATP production is accompanied by increased mitochondrial Ca2+ content and proton leakage as the infection proceeds. Overall, the significant structural and functional changes in the mitochondria triggered by the viral invasion are tightly connected to the progression of the virus infection.
- Published
- 2024
28. Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
- Author
-
Phan, Tin, Zitzmann, Carolin, Chew, Kara W, Smith, Davey M, Daar, Eric S, Wohl, David A, Eron, Joseph J, Currier, Judith S, Hughes, Michael D, Choudhary, Manish C, Deo, Rinki, Li, Jonathan Z, Ribeiro, Ruy M, Ke, Ruian, Perelson, Alan S, and Team, for the ACTIV-2 A5401 Study
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Immunology ,Infectious Diseases ,Biodefense ,Immunization ,Emerging Infectious Diseases ,Vaccine Related ,Biotechnology ,Prevention ,5.2 Cellular and gene therapies ,Development of treatments and therapeutic interventions ,Infection ,Good Health and Well Being ,Humans ,SARS-CoV-2 ,Antibodies ,Monoclonal ,Spike Glycoprotein ,Coronavirus ,COVID-19 ,COVID-19 Drug Treatment ,Antibodies ,Viral ,Drug Resistance ,Viral ,Viral Load ,Antiviral Agents ,Antibodies ,Neutralizing ,ACTIV-2/A5401 Study Team ,Microbiology ,Virology ,Medical microbiology - Abstract
To mitigate the loss of lives during the COVID-19 pandemic, emergency use authorization was given to several anti-SARS-CoV-2 monoclonal antibody (mAb) therapies for the treatment of mild-to-moderate COVID-19 in patients with a high risk of progressing to severe disease. Monoclonal antibodies used to treat SARS-CoV-2 target the spike protein of the virus and block its ability to enter and infect target cells. Monoclonal antibody therapy can thus accelerate the decline in viral load and lower hospitalization rates among high-risk patients with variants susceptible to mAb therapy. However, viral resistance has been observed, in some cases leading to a transient viral rebound that can be as large as 3-4 orders of magnitude. As mAbs represent a proven treatment choice for SARS-CoV-2 and other viral infections, evaluation of treatment-emergent mAb resistance can help uncover underlying pathobiology of SARS-CoV-2 infection and may also help in the development of the next generation of mAb therapies. Although resistance can be expected, the large rebounds observed are much more difficult to explain. We hypothesize replenishment of target cells is necessary to generate the high transient viral rebound. Thus, we formulated two models with different mechanisms for target cell replenishment (homeostatic proliferation and return from an innate immune response antiviral state) and fit them to data from persons with SARS-CoV-2 treated with a mAb. We showed that both models can explain the emergence of resistant virus associated with high transient viral rebounds. We found that variations in the target cell supply rate and adaptive immunity parameters have a strong impact on the magnitude or observability of the viral rebound associated with the emergence of resistant virus. Both variations in target cell supply rate and adaptive immunity parameters may explain why only some individuals develop observable transient resistant viral rebound. Our study highlights the conditions that can lead to resistance and subsequent viral rebound in mAb treatments during acute infection.
- Published
- 2024
29. Wilms’ tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP
- Author
-
Morales, Ayana E, Gumenick, Ruby, Genovese, Caitlyn M, Jang, Yun Yeong, Ouedraogo, Ariene, de Garayo, Maite Ibáñez, Pannellini, Tania, Patel, Sanjay, Bott, Matthew E, Alvarez, Julio, Mun, Sung Soo, Totonchy, Jennifer, Gautam, Archana, de la Mora, Jesus Delgado, Chang, Stephanie, Wirth, Dagmar, Horenstein, Marcelo, Dao, Tao, Scheinberg, David A, Rubinstein, Paul G, Semeere, Aggrey, Martin, Jeffrey, Godfrey, Catherine C, Moser, Carlee B, Matining, Roy M, Campbell, Thomas B, Borok, Margaret Z, Krown, Susan E, and Cesarman, Ethel
- Subjects
Biomedical and Clinical Sciences ,Immunology ,Emerging Infectious Diseases ,Rare Diseases ,HIV/AIDS ,Orphan Drug ,Infectious Diseases ,Cancer ,Hematology ,Aetiology ,2.1 Biological and endogenous factors ,Infection ,Humans ,Sarcoma ,Kaposi ,Herpesvirus 8 ,Human ,CASP8 and FADD-Like Apoptosis Regulating Protein ,WT1 Proteins ,Endothelial Cells ,HIV Infections ,Protein Isoforms ,Tumor Microenvironment ,Microbiology ,Medical Microbiology ,Virology ,Medical microbiology - Abstract
In people living with HIV, Kaposi Sarcoma (KS), a vascular neoplasm caused by KS herpesvirus (KSHV/HHV-8), remains one of the most common malignancies worldwide. Individuals living with HIV, receiving otherwise effective antiretroviral therapy, may present with extensive disease requiring chemotherapy. Hence, new therapeutic approaches are needed. The Wilms' tumor 1 (WT1) protein is overexpressed and associated with poor prognosis in several hematologic and solid malignancies and has shown promise as an immunotherapeutic target. We found that WT1 was overexpressed in >90% of a total 333 KS biopsies, as determined by immunohistochemistry and image analysis. Our largest cohort from ACTG, consisting of 294 cases was further analyzed demonstrating higher WT1 expression was associated with more advanced histopathologic subtypes. There was a positive correlation between the proportion of infected cells within KS tissues, assessed by expression of the KSHV-encoded latency-associated nuclear antigen (LANA), and WT1 positivity. Areas with high WT1 expression showed sparse T-cell infiltrates, consistent with an immune evasive tumor microenvironment. We show that major oncogenic isoforms of WT1 are overexpressed in primary KS tissue and observed WT1 upregulation upon de novo infection of endothelial cells with KSHV. KSHV latent viral FLICE-inhibitory protein (vFLIP) upregulated total and major isoforms of WT1, but upregulation was not seen after expression of mutant vFLIP that is unable to bind IKKƴ and induce NFκB. siRNA targeting of WT1 in latent KSHV infection resulted in decreased total cell number and pAKT, BCL2 and LANA protein expression. Finally, we show that ESK-1, a T cell receptor-like monoclonal antibody that recognizes WT1 peptides presented on MHC HLA-A0201, demonstrates increased binding to endothelial cells after KSHV infection or induction of vFLIP expression. We propose that oncogenic isoforms of WT1 are upregulated by KSHV to promote tumorigenesis and immunotherapy directed against WT1 may be an approach for KS treatment.
- Published
- 2024
30. Structure and antigenicity of the divergent human astrovirus VA1 capsid spike
- Author
-
Ghosh, Anisa, Delgado-Cunningham, Kevin, López, Tomás, Green, Kassidy, Arias, Carlos F, and DuBois, Rebecca M
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Biological Sciences ,Foodborne Illness ,Vaccine Related ,Digestive Diseases ,Aetiology ,2.2 Factors relating to the physical environment ,2.1 Biological and endogenous factors ,Infection ,Child ,Humans ,Capsid ,Mamastrovirus ,Capsid Proteins ,Mutation ,Astroviridae Infections ,Phylogeny ,Feces ,Microbiology ,Immunology ,Virology ,Medical microbiology - Abstract
Human astrovirus (HAstV) is a known cause of viral gastroenteritis in children worldwide, but HAstV can cause also severe and systemic infections in immunocompromised patients. There are three clades of HAstV: classical, MLB, and VA/HMO. While all three clades are found in gastrointestinal samples, HAstV-VA/HMO is the main clade associated with meningitis and encephalitis in immunocompromised patients. To understand how the HAstV-VA/HMO can infect the central nervous system, we investigated its sequence-divergent capsid spike, which functions in cell attachment and may influence viral tropism. Here we report the high-resolution crystal structures of the HAstV-VA1 capsid spike from strains isolated from patients with gastrointestinal and neuronal disease. The HAstV-VA1 spike forms a dimer and shares a core beta-barrel structure with other astrovirus capsid spikes but is otherwise strikingly different, suggesting that HAstV-VA1 may utilize a different cell receptor, and an infection competition assay supports this hypothesis. Furthermore, by mapping the capsid protease cleavage site onto the structure, the maturation and assembly of the HAstV-VA1 capsid is revealed. Finally, comparison of gastrointestinal and neuronal HAstV-VA1 sequences, structures, and antigenicity suggests that neuronal HAstV-VA1 strains may have acquired immune escape mutations. Overall, our studies on the HAstV-VA1 capsid spike lay a foundation to further investigate the biology of HAstV-VA/HMO and to develop vaccines and therapeutics targeting it.
- Published
- 2024
31. The universal suppressor mutation restores membrane budding defects in the HSV-1 nuclear egress complex by stabilizing the oligomeric lattice.
- Author
-
Draganova, Elizabeth B, Wang, Hui, Wu, Melanie, Liao, Shiqing, Vu, Amber, Gonzalez-Del Pino, Gonzalo L, Zhou, Z Hong, Roller, Richard J, and Heldwein, Ekaterina E
- Subjects
Biochemistry and Cell Biology ,Biological Sciences ,Sexually Transmitted Infections ,Generic health relevance ,Herpesvirus 1 ,Human ,Suppression ,Genetic ,Cell Nucleus ,Nuclear Envelope ,Herpesviridae ,Virus Release ,Microbiology ,Immunology ,Medical Microbiology ,Virology ,Medical microbiology - Abstract
Nuclear egress is an essential process in herpesvirus replication whereby nascent capsids translocate from the nucleus to the cytoplasm. This initial step of nuclear egress-budding at the inner nuclear membrane-is coordinated by the nuclear egress complex (NEC). Composed of the viral proteins UL31 and UL34, NEC deforms the membrane around the capsid as the latter buds into the perinuclear space. NEC oligomerization into a hexagonal membrane-bound lattice is essential for budding because NEC mutants designed to perturb lattice interfaces reduce its budding ability. Previously, we identified an NEC suppressor mutation capable of restoring budding to a mutant with a weakened hexagonal lattice. Using an established in-vitro budding assay and HSV-1 infected cell experiments, we show that the suppressor mutation can restore budding to a broad range of budding-deficient NEC mutants thereby acting as a universal suppressor. Cryogenic electron tomography of the suppressor NEC mutant lattice revealed a hexagonal lattice reminiscent of wild-type NEC lattice instead of an alternative lattice. Further investigation using x-ray crystallography showed that the suppressor mutation promoted the formation of new contacts between the NEC hexamers that, ostensibly, stabilized the hexagonal lattice. This stabilization strategy is powerful enough to override the otherwise deleterious effects of mutations that destabilize the NEC lattice by different mechanisms, resulting in a functional NEC hexagonal lattice and restoration of membrane budding.
- Published
- 2024
32. Elimination of Chlamydia muridarum from the female reproductive tract is IL-12p40 dependent, but independent of Th1 and Th2 cells
- Author
-
Rixon, Jordan A, Fong, Kevin D, Morris, Claire, Nguyen, Alana T, Depew, Claire E, and McSorley, Stephen J
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Clinical Sciences ,Immunology ,Immunization ,Contraception/Reproduction ,Vaccine Related ,Prevention ,Infectious Diseases ,Sexually Transmitted Infections ,3.4 Vaccines ,2.1 Biological and endogenous factors ,1.1 Normal biological development and functioning ,Underpinning research ,Aetiology ,Prevention of disease and conditions ,and promotion of well-being ,Inflammatory and immune system ,Infection ,Good Health and Well Being ,Animals ,Female ,Mice ,CD4-Positive T-Lymphocytes ,Chlamydia Infections ,Chlamydia muridarum ,Interleukin-12 Subunit p40 ,Mice ,Inbred C57BL ,Th1 Cells ,Th17 Cells ,Th2 Cells ,Microbiology ,Virology ,Medical microbiology - Abstract
Chlamydia vaccine approaches aspire to induce Th1 cells for optimal protection, despite the fact that there is no direct evidence demonstrating Th1-mediated Chlamydia clearance from the female reproductive tract (FRT). We recently reported that T-bet-deficient mice can resolve primary Chlamydia infection normally, undermining the potentially protective role of Th1 cells in Chlamydia immunity. Here, we show that T-bet-deficient mice develop robust Th17 responses and that mice deficient in Th17 cells exhibit delayed bacterial clearance, demonstrating that Chlamydia-specific Th17 cells represent an underappreciated protective population. Additionally, Th2-deficient mice competently clear cervicovaginal infection. Furthermore, we show that sensing of IFN-γ by non-hematopoietic cells is essential for Chlamydia immunity, yet bacterial clearance in the FRT does not require IFN-γ secretion by CD4 T cells. Despite the fact that Th1 cells are not necessary for Chlamydia clearance, protective immunity to Chlamydia is still dependent on MHC class-II-restricted CD4 T cells and IL-12p40. Together, these data point to IL-12p40-dependent CD4 effector maturation as essential for Chlamydia immunity, and Th17 cells to a lesser extent, yet neither Th1 nor Th2 cell development is critical. Future Chlamydia vaccination efforts will be more effective if they focus on induction of this protective CD4 T cell population.
- Published
- 2024
33. The association between influenza vaccination, cardiovascular mortality and hospitalization: A living systematic review and prospective meta-analysis
- Author
-
Liu, Rong, Fan, Yihang, Patel, Anushka, Liu, Hueiming, Du, Xin, Liu, Bette, and Di Tanna, Gian Luca
- Subjects
Biological Sciences ,Agricultural and Veterinary Sciences ,Medical and Health Sciences ,Virology ,Biomedical and clinical sciences ,Health sciences - Published
- 2024
34. Randomized Trial of a “Dynamic Choice” Patient-Centered Care Intervention for Mobile Persons With HIV in East Africa
- Author
-
Ayieko, James, Balzer, Laura B, Inviolata, Colette, Kakande, Elijah, Opel, Fred, Wafula, Erick M, Kabami, Jane, Owaraganise, Asiphas, Mwangwa, Florence, Nakato, Hellen, Bukusi, Elizabeth A, Camlin, Carol S, Charlebois, Edwin D, Bacon, Melanie C, Petersen, Maya L, Kamya, Moses R, Havlir, Diane V, Chamie, Gabriel, and Team, SEARCH Study
- Subjects
Health Services and Systems ,Biomedical and Clinical Sciences ,Health Sciences ,Clinical Research ,Clinical Trials and Supportive Activities ,Infectious Diseases ,Sexually Transmitted Infections ,HIV/AIDS ,Infection ,Good Health and Well Being ,Female ,Humans ,Adult ,Male ,HIV Infections ,Kenya ,Uganda ,Ambulatory Care Facilities ,Patient-Centered Care ,mobile ,HIV retention ,ART possession ,viral suppression ,SEARCH Study Team ,Clinical Sciences ,Public Health and Health Services ,Virology ,Clinical sciences ,Epidemiology ,Public health - Abstract
BackgroundPersons with HIV (PWH) with high mobility face obstacles to HIV care engagement and viral suppression. We sought to understand whether a patient-centered intervention for mobile PWH would improve viral suppression and retention in care, and if so, which subgroups would benefit most.MethodsIn a randomized trial, we evaluated the effect of an intervention designed to address barriers to care among mobile (≥2 weeks out of community in previous year) PWH with viral nonsuppression or recent missed visits in Kenya and Uganda (NCT04810650). The intervention included dynamic choice of a "travel pack" (emergency antiretroviral therapy [ART] supply, discrete ART packaging, and travel checklist), multimonth and offsite refills, facilitated transfer to out-of-community clinics, and hotline access to a mobility coordinator. The primary outcome was viral suppression (
- Published
- 2024
35. Intimate partner violence and adherence to PrEP and ART among Ugandan HIV serodifferent couples.
- Author
-
Thomas, Dorothy, Nakabugo, Lylianne, Nambi, Florence, Kibuuka, Joseph, Muwonge, Timothy, Feutz, Erika, Thomas, Katherine, Simoni, Jane, Montgomery, Elizabeth, Ware, Norma, Wyatt, Monique, Katz, Ingrid T, Kadama, Herbert, Mujugira, Andrew, and Heffron, Renee
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,HIV/AIDS ,Behavioral and Social Science ,Clinical Research ,Violence Research ,Prevention ,Mental Health ,Violence Against Women ,Clinical Trials and Supportive Activities ,Infectious Diseases ,Peace ,Justice and Strong Institutions ,Partners PrEP Program Team ,Clinical Sciences ,Public Health and Health Services ,Virology ,Clinical sciences ,Epidemiology ,Public health - Abstract
BackgroundIntimate partner violence (IPV) is associated with increased risk of HIV acquisition and reduced engagement in HIV care. There is limited understanding of the ways in which IPV exposure and other maladaptive relationship dynamics may influence adherence to antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) for individuals in committed, HIV serodifferent partnerships.MethodsWe used binomial generalized linear mixed effect regression models to evaluate the association between IPV exposure and ART/PrEP adherence among members of serodifferent couples in Uganda. Secondarily, we assessed the association between relationship powerlessness and ART/PrEP adherence.ResultsWe enrolled and followed both partners in 149 heterosexual serodifferent couples. The partner living with HIV was female in 64% of couples. IPV exposure was associated with low ART adherence (15% vs. 5% in quarters with no IPV, odds ratio [OR]: 4.78, 95% confidence interval [CI] 1.48 - 15.42) but not low PrEP adherence (33% vs. 36%, p=0.69). Among HIV-negative individuals, those reporting moderate relationship powerlessness were less likely to have poor PrEP adherence compared to those with low relationship powerlessness (20% vs. 30%, OR: 0.57, 95% CI 0.36 - 0.90). We observed no association between relationship powerlessness and ART adherence.ConclusionsWe found that IPV exposure was associated with low adherence to ART and that relationship powerlessness was associated with good adherence to PrEP. These findings contribute to the evidence base outlining the influence of IPV and relationship power on ART/PrEP adherence for individuals in HIV serodifferent unions.
- Published
- 2023
36. Chatbots for HIV Prevention and Care: a Narrative Review
- Author
-
van Heerden, Alastair, Bosman, Shannon, Swendeman, Dallas, and Comulada, Warren Scott
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Immunology ,Infectious Diseases ,HIV/AIDS ,Prevention ,Behavioral and Social Science ,8.1 Organisation and delivery of services ,Health and social care services research ,Good Health and Well Being ,Humans ,HIV Infections ,Privacy ,HIV prevention ,Chatbots ,Conversational agents ,Large language models ,Generative AI ,Medical Microbiology ,Virology ,Clinical sciences - Abstract
Purpose of reviewTo explore the intersection of chatbots and HIV prevention and care. Current applications of chatbots in HIV services, the challenges faced, recent advancements, and future research directions are presented and discussed.Recent findingsChatbots facilitate sensitive discussions about HIV thereby promoting prevention and care strategies. Trustworthiness and accuracy of information were identified as primary factors influencing user engagement with chatbots. Additionally, the integration of AI-driven models that process and generate human-like text into chatbots poses both breakthroughs and challenges in terms of privacy, bias, resources, and ethical issues. Chatbots in HIV prevention and care show potential; however, significant work remains in addressing associated ethical and practical concerns. The integration of large language models into chatbots is a promising future direction for their effective deployment in HIV services. Encouraging future research, collaboration among stakeholders, and bold innovative thinking will be pivotal in harnessing the full potential of chatbot interventions.
- Published
- 2023
37. Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation
- Author
-
Killion, Jordan A, Magana, Christopher, Cepeda, Javier A, Vo, Anh, Hernandez, Maricris, Cyr, Cassandra L, Heskett, Karen M, Wilson, David P, Zivin, Joshua Graff, Zúñiga, María L, Pines, Heather A, Garfein, Richard S, Vickerman, Peter, Terris-Prestholt, Fern, Wynn, Adriane, and Martin, Natasha K
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,Behavioral and Social Science ,Liver Disease ,Digestive Diseases ,Hepatitis - C ,Emerging Infectious Diseases ,HIV/AIDS ,Prevention ,Substance Misuse ,Hepatitis ,Infectious Diseases ,Drug Abuse (NIDA only) ,Infection ,Good Health and Well Being ,Humans ,Substance Abuse ,Intravenous ,Needle-Exchange Programs ,HIV Infections ,Hepatitis C ,Hepacivirus ,costs ,global cost extrapolation ,harm reduction ,needle and syringe programs ,people who inject drugs ,syringe exchange program ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Virology ,Biomedical and clinical sciences ,Health sciences - Abstract
BackgroundNeedle and syringe programs (NSPs) are effective at preventing HIV and hepatitis C virus (HCV) among people who inject drugs (PWID), yet global coverage is low, partly because governments lack data on the cost and cost-effectiveness of NSP in their countries to plan and fund their responses. We conducted a global systematic review of unit costs of NSP provision to inform estimation of cost drivers and extrapolated costs to other countries.MethodsWe conducted a systematic review to extract data on the cost per syringe distributed and its cost drivers. We estimated the impact of country-level and program-level variables on the cost per syringe distributed using linear mixed-effects models. These models were used to predict unit costs of NSP provision, with the best performing model used to extrapolate the cost per syringe distributed for 137 countries. The total cost for a comprehensive NSP (200 syringes per PWID/year) was also estimated for 68 countries with PWID population size estimates.ResultsWe identified 55 estimates of the unit cost per syringe distributed from 14 countries. Unit costs were extrapolated for 137 countries, ranging from $0.08 to $20.77 (2020 USD) per syringe distributed. The total estimated spend for a high-coverage, comprehensive NSP across 68 countries with PWID size estimates is $5 035 902 000 for 10 887 500 PWID, 2.1-times higher than current spend.ConclusionOur review identified cost estimates from high-income, upper-middle-income, and lower-middle-income countries. Regression models may be useful for estimating NSP costs in countries without data to inform HIV/HCV prevention programming and policy.
- Published
- 2023
38. Detection and comparison of SARS-CoV-2 antibody produced in naturally infected patients and vaccinated individuals in Addis Ababa, Ethiopia: multicenter cross-sectional study.
- Author
-
Bashea, Chala, Gize, Addisu, Lejisa, Tadesse, Bikila, Demiraw, Zerihun, Betselot, Challa, Feyissa, Melese, Daniel, Gebreyohanns, Alganesh, Gorems, Kasahun, Ali, Solomon, Hundie, Gadissa Bedada, Tola, Habteyes Hailu, and Tsegaye, Wondewosen
- Abstract
Background: Natural infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or vaccination triggers antibody production against key viral antigens. However, there is limited evidence on the levels of antibodies produced in naturally infected individuals compared to those vaccinated in Ethiopia. Therefore, we aimed to detect and compare SARS-CoV-2 antibodies produced by naturally infected and vaccinated individuals. Materials and methods: We conducted a multicenter cross-sectional study among a total of 355 naturally infected and 355 vaccinated individuals from November 2022 to April 2023 at 10 selected health facilities in Addis Ababa, Ethiopia. We enrolled the participants consecutively upon their arrival at health facilities until the required sample size was achieved. We used a structured questionnaire to collect data on the demographic and clinical characteristics of the participants. We also collected 3–5 ml of blood samples from all participants and tested for anti-Spike (anti-S) and anti-nucleocapsid (anti-N) antibodies using Cobas 6000. We utilized frequency, mean, or median to describe the data, the Mann-Whitney U test to compare groups, and a generalized linear regression model to assess factors associated with anti-S antibody concentration. We analyzed the data with SPSS version 26, and the level of significance was set at P-value < 0.05. Results: Of the naturally infected participants, 352 (99.5%) had anti-S antibodies and all (100%) had anti-N antibodies, whereas among vaccinated participants, all (100%) had anti-S antibodies, while 323 (91.6%) had anti-N antibodies. Anti-S antibodies produced by vaccinated individuals were significantly (P < 0.001) higher than those produced as a result of natural infection. Being young (P = 0.004), having hypertension (P < 0.001), and having diabetes (P < 0.001) were significantly associated with lower anti-S antibody levels, while being recently vaccinated and having a higher number of vaccine doses were significantly associated with higher anti-S antibody concentrations in vaccinated participants. Having diabetes (P < 0.001) were significantly associated with lower anti-S concentrations in participants who were naturally infected. Conclusion: There is a high seropositivity rate in both naturally infected and vaccinated individuals. However, vaccinated individuals had higher levels of SARS-CoV-2 antibodies than those who were naturally infected, which highlights the significant contribution of vaccination in increasing the protection of COVID-19 in Ethiopia. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Chronic and Neurotropic: A Paradigm-Challenging Case of Dengue Virus Encephalitis in a Patient With Advanced HIV Infection.
- Author
-
Marinelli, Tina, Masters, Jeffrey, Buckland, Michael E, Lee, Maggie, Rawlinson, William, Kim, Ki Wook, Urriola, Nicolas, and Hal, Sebastiaan van
- Subjects
- *
HIV infection complications , *CEREBROSPINAL fluid examination , *BIOPSY , *GENOMICS , *ANTIRETROVIRAL agents , *PATIENTS , *VIROLOGY , *AZITHROMYCIN , *CD4 lymphocyte count , *HOSPITAL admission & discharge , *IMMUNOGLOBULINS , *TENOFOVIR , *DENGUE , *HIV infections , *STATUS epilepticus , *MAGNETIC resonance imaging , *TREATMENT effectiveness , *CHRONIC diseases , *EMTRICITABINE , *HEPATITIS B , *INTENSIVE care units , *CO-trimoxazole , *VIRAL encephalitis , *ANTIBIOTIC prophylaxis , *MIXED infections , *LUMBAR puncture , *DISEASE complications , *SYMPTOMS - Abstract
A 32-year-old female with advanced human immunodeficiency virus infection presented to an Australian hospital with subacute, worsening symptoms of encephalitis. Metagenomic sequencing and Dengue NS3 antigen staining of brain tissue confirmed active dengue virus (DENV) encephalitis. The most recent possible DENV exposure was months prior in West Africa, indicating chronicity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Short-Term Efficacy of Tenofovir Alafenamide in Acute-On-Chronic Liver Failure: A Single Center Experience.
- Author
-
Li, Zhiqin, Zhu, Ruirui, Dong, Jianxia, Gao, Yinghui, and Yan, Jingya
- Subjects
- *
PATIENT safety , *VIROLOGY , *RESEARCH funding , *TENOFOVIR , *DESCRIPTIVE statistics , *BILIRUBIN , *ANTIVIRAL agents , *VIRAL antigens , *LIVER diseases , *HEPATITIS B , *DRUG efficacy , *LIVER failure , *LIVER transplantation , *BIOMARKERS , *EVALUATION - Abstract
Background: Patients with acute-on-chronic liver failure (ACLF) who take entecavir (ETV) and tenofovir disoproxil fumarate (TDF) experience a reduction in hepatic events and mortality. The effectiveness of tenofovir alafenamide (TAF) was not well investigated. This study was aim to compare the antiviral efficacy and mortality between TAF and ETV in patients with ACLF caused by the hepatitis B virus (HBV). Methods: One hundred and six patients with HBV-ACLF who received TAF (25 mg/day) and ETV (0.5 mg/day) for 12 weeks were analyzed. The primary endpoints were overall mortality and liver transplantation (LT) at week 12. Biochemical responses, virologic responses, mortality, drug safety, and side effects were evaluated. Results: At 4 and 12 weeks of TAF treatment, patients showed significantly higher HBV-DNA reduction (P <.001), higher HBV-DNA undetectability rates (P <.001), and lower HBV DNA levels (P <.001) in serum. Lower Child-Turcotte-Pugh (CTP) scores (P =.003) were observed at 4 weeks in the TAF group, although the CTP scores showed no difference between TAF group and ETV group at 12 weeks (P = 1.143). Lower alanine aminotransferase (ALT) levels of patients in the TAF group at week 4 and 12 were observed (P =.023 and P <.0001, separately). The mortality of TAF group was lower after 4 weeks of treatment (P =.038); however, the 2 groups had similar mortality rates at week 8 and 12. Among the causes of death in HBV-ACLF patients, we found the same incidence of liver-related problems in both groups (P >.05). Conclusions: This study showed that ACLF patients with chronic HBV infection treated with TAF had a rapid decline in HBV DNA, a higher rate of ALT reduction and improved CTP scores compared to the ETV group, thereby improving patient survival. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Epitranscriptomic m5C methylation of SARS-CoV-2 RNA regulates viral replication and the virulence of progeny viruses in the new infection.
- Author
-
Hongyun Wang, Jiangpeng Feng, Zhiying Fu, Tianmo Xu, Jiejie Liu, Shimin Yang, Yingjian Li, Jikai Deng, Yuzhen Zhang, Ming Guo, Xin Wang, Zhen Zhang, Zhixiang Huang, Ke Lan, Li Zhou, and Yu Chen
- Subjects
- *
SARS-CoV-2 , *VIRUS virulence , *RNA methylation , *VIRUS diseases , *VIRAL replication , *VIROLOGY - Abstract
While the significance of N6-methyladenosine (m6A) in viral regulation has been extensively studied, the functions of 5-methylcytosine (m5C) modification in viral biology remain largely unexplored. In this study, we demonstrate that m5C is more abundant than m6A in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and provide a comprehensive profile of the m5C landscape of SARS-CoV-2 RNA. Knockout of NSUN2 reduces m5C levels in SARS-CoV-2 virion RNA and enhances viral replication. Nsun2 deficiency mice exhibited higher viral burden and more severe lung tissue damages. Combined RNA-Bis-seq and m5C-MeRIP-seq identified the NSUN2-dependent m5C-methylated cytosines across the positive-sense genomic RNA of SARS-CoV-2, and the mutations of these cytosines enhance RNA stability. The progeny SARS-CoV-2 virions from Nsun2 deficiency mice with low levels of m5C modification exhibited a stronger replication ability. Overall, our findings uncover the vital role played by NSUN2-mediated m5C modification during SARS-CoV-2 replication and propose a host antiviral strategy via epitranscriptomic addition of m5C methylation to SARS-CoV-2 RNA. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. A Randomized Study to Determine the Effect of a Culturally Focused Video Intervention on Improving HPV Vaccine Intentions in a Christian Population in the United States.
- Author
-
Redd, David S., Altman, Jessica D., Jensen, Jamie L., Sloan-Aagard, Chantel D., Crook, Triston B., Asay, Aaron E., Nielson, Bryce U., Larson, Ruth J., Miner, Dashiell S., and Poole, Brian D.
- Subjects
- *
PARENTS , *BACTERIAL vaccines , *STATISTICAL models , *SCALE analysis (Psychology) , *PEARSON correlation (Statistics) , *CHRISTIANS , *HEALTH attitudes , *DATA analysis , *VIROLOGY , *RESEARCH funding , *CULTURE , *VACCINE effectiveness , *VACCINATION , *STATISTICAL sampling , *HUMAN papillomavirus vaccines , *PAPILLOMAVIRUSES , *RANDOMIZED controlled trials , *DESCRIPTIVE statistics , *FAMILIES , *CANCER patients , *MANN Whitney U Test , *CHI-squared test , *QUANTITATIVE research , *ATTITUDE (Psychology) , *SURVEYS , *PRE-tests & post-tests , *INTENTION , *STORYTELLING , *RELIGION , *VACCINE hesitancy , *STATISTICS , *TEST validity , *HEALTH education , *VIDEO recording ,CERVIX uteri tumors - Abstract
Safe and effective vaccines have been developed that protect against high-risk strains of HPV, but uptake is relatively low. We previously identified factors such as sexual attitudes and HPV knowledge that impact the intent of Christian parents to vaccinate their children against HPV. We hypothesized that culturally specific interventions in the form of short videos would be effective at improving HPV vaccine intentions and attitudes. We made three short educational videos, one with a Christian focus, one informational about HPV, and one control. Videos were distributed electronically with accompanying surveys, and responses were measured before and after watching a randomly selected video. The religious-focused and educational interventions significantly (p < 0.0001, p = 0.0015) improved intentions towards HPV vaccination. The religiously-focused video also significantly diminished the belief that the HPV vaccine is unnecessary because of a family's values (p = 0.014). Parents significantly credited both interventions with improving their intent to vaccinate their children against HPV (p < 0.001 for both). These results suggest that culturally focused educational interventions are effective at influencing vaccine intentions and attitudes, even when those are based on religious or cultural feelings. Highly specific interventions are likely to be necessary for optimal improvement in vaccine hesitancy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Nudiviruses in free-living and parasitic arthropods: evolutionary taxonomy.
- Author
-
Petersen, Jirka Manuel, Burgess, Amy L., van Oers, Monique M., Herniou, Elisabeth A., and Bojko, Jamie
- Subjects
- *
CRETACEOUS Period , *INSECT evolution , *INSECT hosts , *CLIMATIC zones , *CRUSTACEA - Abstract
An updated phylogenomic tree of the Nudiviridae is presented, including 49 species, proposing two genera associated with ectoparasitic insects. Evolution of the family Nudiviridae is estimated to have occurred in the mid-Devonian, matching the timeline of the insect's evolution. All the crustacean-infecting nudiviruses have likely emerged from a single common ancestor (~143 million years ago), perhaps transmitted to Jurassic crustaceans by an insect host. The Nudiviridae have a proclivity for ectoparasitic arthropods (i.e., lice and fleas), linked to multiple diversification events in the Triassic (early Betanudivirinae split), Jurassic (involving ectoparasitic hosts of alphanudiviruses), and Cretaceous periods (Zeta/Etanudivirus diversification). Nudiviruses inhabit various geographical and climatic zones, including members from subpolar habitats. The nudiviruses (family: Nudiviridae) are large double-stranded DNA (dsDNA) viruses that infect insects and crustaceans, and have most recently been identified from ectoparasitic members (fleas and lice). This virus family was created in 2014 and has since been expanded via the discovery of multiple novel viral candidates or accepted members, sparking the need for a new taxonomic and evolutionary overview. Using current information (including data from public databases), we construct a new comprehensive phylogeny, encompassing 49 different nudiviruses. We use this novel phylogeny to propose a new taxonomic structure of the Nudiviridae by suggesting two new viral genera (Zetanudivirus and Etanudivirus), from ectoparasitic lice. We detail novel emerging relationships between nudiviruses and their hosts, considering their evolutionary history and ecological role. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Brief Report: Characterizing HIV Drug Resistance in Cases of Vertical Transmission in the VESTED Randomized Antiretroviral Treatment Trial.
- Author
-
Bishop, Marley D., Korutaro, Violet, Boyce, Ceejay L., Beck, Ingrid A., Styrchak, Sheila M., Knowles, Kevin, Ziemba, Lauren, Brummel, Sean S., Coletti, Anne, Jean-Philippe, Patrick, Chakhtoura, Nahida, Vhembo, Tichaona, Cassim, Haseena, Owor, Maxensia, Fairlie, Lee, Moyo, Sikhulile, Chinula, Lameck, Lockman, Shahin, and Frenkel, Lisa M.
- Abstract
Introduction: VESTED (Virologic Efficacy and Safety of ART combinations with tenofovir alafenamide fumarate (TAF)/tenofovir disoproxil fumarate (TDF), efavirenz, and dolutegravir)(NCT03048422) compared the safety and efficacy of 3 antiretroviral treatment (ART) regimens in pregnant and postpartum women: dolutegravir + emtricitabine/TAF, dolutegravir + emtricitabine/TDF, and efavirenz/emtricitabine/TDF. Vertical HIV transmission (VT) occurred in 4 of 617 live-born infants (0.60%), who were evaluated for HIV drug resistance (HIVDR) and other risk factors. Setting: In 2018–2020, pregnant women (weeks 14–28) living with HIV underwent ≤14 days of ART were enrolled at 22 international sites and followed with their infants through 50 weeks postpartum. Methods: HIV sequences derived by single-genome amplification from longitudinally collected specimens were assessed from VT cases for HIVDR in protease, reverse transcriptase, integrase, and the nef 3′polypurine tract (3′PPT). Results: The 4 case mothers were prescribed efavirenz-based ART for 1–7 days before randomization to study ART. Their infants received postnatal nevirapine ± zidovudine prophylaxis and were breastfed. A total of 833 single-genome amplification sequences were derived. The "major" (Stanford HIVDR Score ≥60) non-nucleoside reverse transcriptase inhibitor (NNRTI) mutation (K103N) was detected persistently in 1 viremic mother and likely contributed to VT of HIVDR. Major NNRTI HIVDR mutations were detected in all 3 surviving infants. Neither integrase nor high frequencies of 3′PPT mutations conferring dolutegravir HIVDR were detected. The timing of HIV infant diagnosis, plasma HIV RNA levels, and HIVDR suggests 1 in utero, 1 peripartum, 1 early, and 1 late breastfeeding transmission. Conclusions: VT was rare. New-onset NNRTI HIVDR in case mothers was likely from efavirenz ART or dolutegravir ART prescribed before study, and in 1 case, it seemed transmitted to the infant despite nevirapine prophylaxis. NCBI GenBank Accession Numbers: OQ911992-OQ912874. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Herpesviruses in migrating procellariforms, northeastern Brazil.
- Author
-
Sacristán, Carlos, Duarte-Benvenuto, Aricia, Navas-Suárez, Pedro Enrique, Zamana-Ramblas, Roberta, Baes, Laura, Codeas, Barbara Sophia, Pavanelli, Larissa, Ikeda, Joana, Catão-Dias, José Luiz, and Ewbank, Ana Carolina
- Abstract
Seabirds are one of the most threatened avian groups. Viruses, including herpesvirus, represent considerable threats to marine avifauna. Herein, our goal was to survey herpesvirus in Procellariiformes that stranded in Brazil between June and July 2021. We analyzed 12 Cory's shearwaters (Calonectris borealis), two Great Shearwaters (Ardenna gravis, syn. Puffinus gravis) and one Yellow-nosed Albatross (Thalassarche chlororynchos) found in an unusual mortality event in Bahía state, northeastern Brazil. After necropsy, selected tissue samples were tested for herpesvirus using a broad-range nested PCR. Overall, 20% (3/15) of the birds were herpesvirus-positive, i.e., two Cory's Shearwaters and one Great Shearwater. One alphaherpesvirus sequence type was identified in each shearwater species, classified into the genus Mardivirus. This study describes two likely novel herpesviruses in shearwaters, contributing to the currently very scarce data regarding infectious agents in Procellariiformes. Further studies are necessary to evaluate the presence and characteristics of herpesvirus in Procellariiformes, and the presence (or not) of related disease in order to understand the epidemiology of this infectious agent and eventually contribute to the conservation of this endangered seabird group. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Complete combinatorial mutational enumeration of a protein functional site enables sequence‐landscape mapping and identifies highly‐mutated variants that retain activity.
- Author
-
Colom, Mireia Solà, Vučinić, Jelena, Adolf‐Bryfogle, Jared, Bowman, James W., Verel, Sébastien, Moczygemba, Isabelle, Schiex, Thomas, Simoncini, David, and Bahl, Christopher D.
- Abstract
Understanding how proteins evolve under selective pressure is a longstanding challenge. The immensity of the search space has limited efforts to systematically evaluate the impact of multiple simultaneous mutations, so mutations have typically been assessed individually. However, epistasis, or the way in which mutations interact, prevents accurate prediction of combinatorial mutations based on measurements of individual mutations. Here, we use artificial intelligence to define the entire functional sequence landscape of a protein binding site in silico, and we call this approach Complete Combinatorial Mutational Enumeration (CCME). By leveraging CCME, we are able to construct a comprehensive map of the evolutionary connectivity within this functional sequence landscape. As a proof of concept, we applied CCME to the ACE2 binding site of the SARS‐CoV‐2 spike protein receptor binding domain. We selected representative variants from across the functional sequence landscape for testing in the laboratory. We identified variants that retained functionality to bind ACE2 despite changing over 40% of evaluated residue positions, and the variants now escape binding and neutralization by monoclonal antibodies. This work represents a crucial initial stride toward achieving precise predictions of pathogen evolution, opening avenues for proactive mitigation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Composting and fermentation: mitigating hop latent viroid infection risk in hop residues.
- Author
-
Hagemann, Michael Helmut, Treiber, Charlotte, Sprich, Elke, Born, Ute, Lutz, Kathrin, Stampfl, Johannes, and Radišek, Sebastjan
- Abstract
Hop cultivation, integral to the brewing industry, faces challenges from viroids, especially the citrus bark cracking viroid (CBCVd) but also the hop latent viroid (HLVd) influences hop cone quality. We focused on the degradation kinetics of HLVd thereby covering compost, silage, and digestate made from hop residues. In this study, HLVd serves as a model for understanding CBCVd, which causes significant stunting and yield losses in European hop crops. Composting experiments revealed that although composting significantly lowers HLVd levels, complete degradation within 7 weeks is not guaranteed, with loose compost showing a more rapid reduction than compacted variants. Infectivity experiments conducted using inocula obtained from HLVd-infected hop plant residues exposed to composting, ensiling, and biogas digestate did not result in the transmission of HLVd to viroid-free plants. Also extracting and analyzing the soil-root mixture of plants inoculated with HLVd-infected hop residues did not show evidence for viroid persistence. Degradation experiments further differentiated between the physiochemical and biological influences on viroid and viroid-like random RNA stability, showing that higher temperatures of 50 °C enhance degradation over 40 °C, and pH levels of 5 or 7 are slowing degradation. In contrast deionized water or a pH of 4 or 9 enhances viroid degradation. Adding extracts from digestate accelerated the process indicating a role of biological activity. Interestingly, a viroid-like random RNA with similar physiochemical properties, showed to degrade faster compared to HLVd, suggesting high robustness of the actual viroid secondary structure. These findings offer valuable insights into managing HLVd in hops and potentially other crops, highlighting effective strategies to mitigate viroid spread, and contributing to broader understanding of RNA degradation in agriculture. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. A ~40-kb flavi-like virus does not encode a known error-correcting mechanism.
- Author
-
Petrone, Mary E., Grove, Joe, Mélade, Julien, Mifsud, Jonathon C. O., Parry, Rhys H., Marzinelli, Ezequiel M., and Holmes, Edward C.
- Subjects
- *
GENOME size , *VIRAL genomes , *RNA viruses , *NIDOVIRUSES , *NUCLEIC acids - Abstract
It is commonly held that there is a fundamental relationship between genome size and error rate, manifest as a notional "error threshold" that sets an upper limit on genome sizes. The genome sizes of RNA viruses, which have intrinsically high mutation rates due to a lack of mechanisms for error correction, must therefore be small to avoid accumulating an excessive number of deleterious mutations that will ultimately lead to population extinction. The proposed exceptions to this evolutionary rule are RNA viruses from the order Nidovirales (such as coronaviruses) that encode error-correcting exonucleases, enabling them to reach genome lengths greater than 40 kb. The recent discovery of large-genome flavi-like viruses (Flaviviridae), which comprise genomes up to 27 kb in length yet seemingly do not encode exonuclease domains, has led to the proposal that a proofreading mechanism is required to facilitate the expansion of nonsegmented RNA virus genomes above 30 kb. Herein, we describe a ~40 kb flavi-like virus identified in a Haliclona sponge metatranscriptome that does not encode a known exonuclease. Structural analysis revealed that this virus may have instead captured cellular domains associated with nucleic acid metabolism that have not been previously found in RNA viruses. Phylogenetic inference placed this virus as a divergent pesti-like lineage, such that we have provisionally termed it "Maximus pesti-like virus." This virus represents an instance of a flavi-like virus achieving a genome size comparable to that of the Nidovirales and demonstrates that RNA viruses have evolved multiple solutions to overcome the error threshold. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth Analysis.
- Author
-
Welzen, Berend J van, Lelyveld, Steven F L Van, Beest, Gerjanne Ter, Gisolf, Jet H, Geerlings, Suzanne E, Prins, Jan M, Twillert, Gitte Van, Nieuwkoop, Cees Van, Valk, Marc Van der, Burger, David, and Wensing, Annemarie M J
- Subjects
- *
RILPIVIRINE , *HIV integrase inhibitors , *VIROLOGY , *ANTIRETROVIRAL agents , *HIV , *NON-nucleoside reverse transcriptase inhibitors , *BODY mass index , *ORAL drug administration , *INJECTIONS , *DRUG monitoring , *PROTEASE inhibitors , *CISGENDER people , *VIREMIA , *POLYNEUROPATHIES , *TREATMENT failure , *GENERIC drug substitution , *TRANS women , *GENETIC mutation , *CONFIDENCE intervals , *GENOTYPES , *SEQUENCE analysis , *TIME , *B cell lymphoma - Abstract
Background Long-acting (LA) injectable therapy with cabotegravir (CAB) and rilpivirine (RPV) is currently used as maintenance treatment for human immunodeficiency virus type 1, and has a low risk for virological failure (VF). Although the risk is low, the circumstances and impact of VF in the real-world setting merit further evaluation. Methods We performed an in-depth clinical, virological, and pharmacokinetic analysis on the reasons behind and the impact of VF during LA CAB/RPV therapy in 5 cases from the Netherlands. Genotypic resistance testing was performed after the occurrence of VF, and drug plasma (trough) concentrations were measured after VF was established and on any other samples to assess on-treatment drug levels. CAB and RPV drug levels that were below the first quartile of the population cutoff (≤Q1) were considered to be low. Results Five cases who were eligible for LA CAB/RPV experienced VF despite a low predicted risk at baseline. Genotypic resistance testing revealed extensive selection of nonnucleoside reverse transcriptase inhibitor–associated mutations in all cases, and integrase strand transfer inhibitor mutations in 4 cases. All cases displayed low drug levels of either CAB, RPV, or both during the treatment course, likely contributing to the occurrence of VF. In 3 cases, we were able to identify the potential mechanisms behind these low drug levels. Conclusions This is the first in-depth multiple case analysis of VF on LA CAB/RPV therapy in a real-world setting. Our observations stress the need to be aware for (evolving) risk factors and the yield of a comprehensive clinical, virological, and pharmacokinetic approach in case of failure. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. "Tear down that wall"--a critical evaluation of bioinformatic resources available for lysin researchers.
- Author
-
Bałdysz, Sophia, Nawrot, Robert, and Barylski, Jakub
- Subjects
- *
HIDDEN Markov models , *LYSINS , *ANTI-infective agents , *RESEARCH personnel , *BACTERIOPHAGES - Abstract
Lytic enzymes, or lysins for short, break down peptidoglycan and interrupt the continuity of the cell wall, which, in turn, causes osmotic lysis of the bacterium. Their ability to destroy bacteria from within makes them promising antimicrobial agents that can be used as alternatives or supplements to antibiotics. In this paper, we bri efly summarize basic terms and concepts used to describe lysin sequences and delineate major lysin groups. More importantly, we describe the domain repertoire found in lysins and critically review bioinformatic tools or databases which are used in studies of these enzymes (with particular emphasis on the repositories of Hidden Markov models). Finally, we present a novel comprehensive, meticulously curated set of lysin-related family and domain models, sort them into clusters that reflect major families, and demonstrate that the selected models can be used to efficiently search for new lysins. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.